Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome(, )

BACKGROUND/AIMS: Alterations in noradrenergic (NE) signaling have been implicated in the pathophysiology of irritable bowel syndrome (IBS), and adrenergic receptors are potential treatment targets. METHODS: To characterize central NE signaling in IBS, 11 patients and 11 healthy controls (HCs) were s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Berman, Steven, Suyenobu, Brandall, Naliboff, Bruce D., Bueller, Joshua, Stains, Jean, Wong, Heng, Mandelkern, Mark, Fitzgerald, Leah, Ohning, Gordon, Gupta, Arpana, Labus, Jennifer S., Tillisch, Kirsten, Mayer, Emeran A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4130741/
https://ncbi.nlm.nih.gov/pubmed/22917679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuroimage.2012.08.028
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg